Phathom Pharmaceuticals Inc’s recently made public that its CFO and CBO Henderson Molly unloaded Company’s shares for reported $16740.0 on Apr 07 ’25. In the deal valued at $4.55 per share,3,678 shares were sold. As a result of this transaction, Henderson Molly now holds 89,868 shares worth roughly $0.39 million.
Then, Parikh Asit bought 10,000 shares, generating $44,200 in total proceeds. Upon buying the shares at $4.42, the Director now owns 85,500 shares.
Before that, Henderson Molly sold 6,583 shares. Phathom Pharmaceuticals Inc shares valued at $43,371 were divested by the CFO and CBO at a price of $6.59 per share. As a result of the transaction, Henderson Molly now holds 93,546 shares, worth roughly $0.41 million.
Cantor Fitzgerald initiated its Phathom Pharmaceuticals Inc [PHAT] rating to an Overweight in a research note published on February 14, 2025; the price target was $23. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Needham also remained covering PHAT and reiterated its “Buy” recommendation on January 05, 2024. H.C. Wainwright started covering the stock on August 09, 2023. It rated PHAT as “a Buy”.
Price Performance Review of PHAT
On Tuesday, Phathom Pharmaceuticals Inc [NASDAQ:PHAT] saw its stock jump 5.06% to $4.36. Over the last five days, the stock has gained 10.10%. Phathom Pharmaceuticals Inc shares have fallen nearly -46.31% since the year began. Nevertheless, the stocks have fallen -52.09% over the past one year. While a 52-week high of $19.71 was reached on 01/02/25, a 52-week low of $3.81 was recorded on 04/10/25. SMA at 50 days reached $5.17, while 200 days put it at $10.28.
Levels Of Support And Resistance For PHAT Stock
The 24-hour chart illustrates a support level at 4.13, which if violated will result in even more drops to 3.90. On the upside, there is a resistance level at 4.52. A further resistance level may holdings at 4.68. The Relative Strength Index (RSI) on the 14-day chart is 44.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.03%. Stochastics %K at 30.61% indicates the stock is a holding.
How much short interest is there in Phathom Pharmaceuticals Inc?
A steep rise in short interest was recorded in Phathom Pharmaceuticals Inc stocks on 2025-04-15, dropping by -2.97 million shares to a total of 11.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 14.36 million shares. There was a decline of -26.1%, which implies that there is a negative sentiment for the stock.
